EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Association Between miRNA-223-3p Levels and Pain Severity in Fibromyalgia Syndrome: A Molecular Approach

Zerrin Barut iD, Özlem Karataş iD, Fatma Tuba Akdeniz, Bürke Çırçırlı, Serpil Demir, Turgay İsbir

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms27010176 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Zerrin Barut und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Sciences, Faculty of Dentistry, Antalya Bilim University, 07910 Antalya, Türkiye. Hauptthemen laut MEDLINE: MicroRNAs, Fibromyalgia, Pain. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibromyalgia Syndrome (FMS) is a chronic syndrome commonly characterized by widespread musculoskeletal pain and fatigue. Current evidence suggests that FMS diagnosis relies on clinical evaluation and patient-reported symptoms. MicroRNAs, which serve as key regulators of gene expression, have been proposed to play a role in the pathogenesis of FMS and other chronic pain syndromes. In this pilot study, miRNA-223-3p expression levels were examined in patients with FMS, and their relationship with pain intensity—assessed using the Visual Analog Scale (VAS)was evaluated. To obtain a broader understanding of the inflammatory response, serum interleukin-1 beta (IL-1β) levels were also measured. miRNA-223-3p expression levels were significantly reduced in the FMS group compared with healthy controls (p < 0.05), whereas IL-1β levels did not differ significantly between the groups (p = 0.1135). The negative correlation between miRNA-223-3p and VAS scores indicates that lower miRNA levels are associated with increased pain severity. Overall, these results suggest that reduced miRNA-223-3p expression levels may be linked to neuroimmune processes and heightened pain perception in FMS. The findings provide valuable preliminary insights that may guide future studies with larger sample sizes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsFibromyalgiaPainHumansFemaleMiddle AgedAdultSeverity of Illness IndexPain MeasurementInterleukin-1betaBiomarkersPilot ProjectsMale

Stichwörter der Autor:innen

Visual Analog Scalebiomarkerchronic painfibromyalgia syndrome (FMS)miRNA-223-3pneuroinflammationpain severity

Substanzen

MicroRNAsMIR223, humanInterleukin-1betaBiomarkers

Autor:innen und Institutionen

  • Department of Basic Medical Sciences, Faculty of Dentistry, Antalya Bilim University, 07910 Antalya, Türkiye.
  • Department of Internal Medicine, Division of Physical Medicine and Rehabilitation, Faculty of Medicine, Akdeniz University, 07070 Antalya, Türkiye.
  • Department of Genetics and Bioengineering, Faculty of Engineering and Naturel Sciences, Istanbul Okan University, 34959 Istanbul, Türkiye.
  • Department of Medical Biotechnology and Medical Biochemistry, Faculty of Medicine, Akdeniz University, 07070 Antalya, Türkiye.
  • Institute of Health Sciences, Department of Molecular Medicine, Yeditepe University, 34755 Istanbul, Türkiye.

ORCID-Profile: Zerrin Barut, Özlem Karataş

Zitieren

APA

Barut, Z., Karataş, Ö., Akdeniz, F. T., Çırçırlı, B., Demir, S., & İsbir, T. (2025). The Association Between miRNA-223-3p Levels and Pain Severity in Fibromyalgia Syndrome: A Molecular Approach. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27010176

Vancouver

Barut Z, Karataş Ö, Akdeniz FT, Çırçırlı B, Demir S, İsbir T. The Association Between miRNA-223-3p Levels and Pain Severity in Fibromyalgia Syndrome: A Molecular Approach. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms27010176

BibTeX
@article{Barut2025,
  author = {Barut, Zerrin and Karataş, Özlem and Akdeniz, Fatma Tuba and Çırçırlı, Bürke and Demir, Serpil and İsbir, Turgay},
  title = {The Association Between miRNA-223-3p Levels and Pain Severity in Fibromyalgia Syndrome: A Molecular Approach},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms27010176}
}
Kostenlos starten →